-
NovoCure's (NVCR) Neutral Rating Reiterated at Wedbush
Source: Buzz FX / 13 Jan 2025 19:36:15 America/Chicago
NovoCure's (NVCR) Neutral Rating Reiterated at Wedbush Written by MarketBeat January 13, 2025 Share Link copied to clipboard. NovoCure ( NASDAQ:NVCR - Get Free Report ) 's stock had its "neutral" rating restated by equities research analyst
Read more...